Skip to main content
Have a personal or library account? Click to login
Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease Cover

Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease

Open Access
|Aug 2024

References

  1. Lindstrom M, DeCleene N, Dorsey H, et al. Global burden of cardiovascular diseases and risks collaboration, 1990–2021. J Am Coll Cardiol. 2022;80:23722425. doi:10.1016/j.jacc.2022.11.001
  2. Dasmahapatra P, Srinivasan SR, Mokha J, Fernandez C, Chen W, Xu J. Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: The Bogalusa heart study. Ann Epidemiol. 2011;21(4):311317. doi:10.1016/j.annepidem.2011.01.007
  3. Asogwa OA, Boateng D, Marzà-Florensa A, et al. Multimorbidity of non-communicable diseases in low-income and middle-income countries: A systematic review and meta-analysis. BMJ Open. 2022;12(1):e049133. doi:10.1136/bmjopen-2021-049133
  4. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 2007;356(3):213215. doi:10.1056/nejmp068177
  5. Ter Braake AD, Shanahan CM, De Baaij JH. Magnesium counteracts vascular calcification: Passive interference or active modulation? Arterioscler Thromb Vasc Biol. 2017;37(8):14311445. doi:10.1161/ATVBAHA.117.309182
  6. Castellano Vázquez JM, Fernández Alvira JM, Fuster V. Primordial prevention: Paramount in cardiovascular prevention. Rev Esp Cardiol (Engl Ed). 2020;73(3):194196. doi:10.1016/j.rec.2019.09.017
  7. Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation. 2019;139(16):e840e878. doi:10.1161/CIR.0000000000000664
  8. Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association. Circulation. 2023;148(20):16361664. doi:10.1161/CIR.0000000000001186
  9. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: A presidential Advisory from the American Heart Association. Circulation. 2023;148(20):16061635. doi:10.1161/CIR.0000000000001184
  10. Castellano Vázquez JM, Fernández Alvira JM, Fuster V. Primordial prevention: Paramount in cardiovascular prevention. Rev Esp Cardiol (Engl Ed). 2020;73(3):194196. doi:10.1016/j.rec.2019.09.017
  11. Ahmed A, Akhter J, Iqbal R, et al. Prevalence and associations of metabolic syndrome in an urban high diabetes risk population in a low/middle-income country. Metab Syndr Relat Disord. 2020;18(5):234242. doi:10.1089/met.2019.0098
  12. George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: The case for increased screening. BMJ Glob Health. 2017; 2(2): e000256. doi:10.1136/bmjgh-2016-000256
  13. Bovet P, Chiolero A, Paccaud F, Banatvala N. Screening for cardiovascular disease risk and subsequent management in low and middle income countries: Challenges and opportunities. Public Health Rev. 2015;36:115. doi:10.1186/s40985-015-0013-0
  14. Ndejjo R, Hassen HY, Wanyenze RK, et al. Community-based interventions for cardiovascular disease prevention in low-and middle-income countries: A systematic review. Public Health Rev. 2021;42:1604018. doi:10.3389/phrs.2021.1604018
  15. Randell EW, Thakur V. Leading POCT networks: Operating POCT programs across multiple sites involving vast geographical areas and rural communities. EJIFCC. 2021;32(2):179189.
  16. National Kidney Foundation of Arizona. Path to wellness program. Accessed July 12, 2024. https://azkidney.org/pathtowellness.
  17. Darnton-Hill I, Nishida C, James WP. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutrition. 2004;7(1A):101121. doi:10.1079/phn2003584
  18. Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: A policy statement from the American Heart Association. Circulation. 2011;124(8):967990. doi:10.1161/cir.0b013e3182285a81
  19. Morton K, Heindl B, Clarkson S, Bittner V. Primordial prevention of atherosclerotic cardiovascular disease: A review of the literature. J Cardiopulm Rehabil Prev. 2022;42(6):389396. doi:10.1097/HCR.0000000000000748
  20. van der Velde M, Matsushita K, Coresh J, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):13411352. doi:10.1038/ki.2010.536
  21. Shroff R, Speer T, Colin S, et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol. 2014;25(11):26582668. doi:10.1681/ASN.2013111212
  22. Murray CJL. The global burden of disease study at 30 years. Nat Med. 2022;28(10):20192026. doi:10.1038/s41591-022-01990-1
  23. Shu J, Jin W. Prioritizing non-communicable diseases in the post-pandemic era based on a comprehensive analysis of the GBD 2019 from 1990 to 2019. Sci Rep. 2023;13(1):13325. doi:10.1038/s41598-023-40595-7
  24. Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):18311843. doi:10.1016/S0140-6736(14)60384-6
  25. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959968. doi:10.1001/jama.2013.184182
  26. Marcus ME, Manne-Goehler J, Theilmann M, et al. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data. Lancet Glob Health. 2022;10(3):e369e379. doi:10.1016/S2214-109X(21)00551-9
  27. Post WS, Watson KE, Hansen S, et al. Racial and ethnic differences in all-cause and cardiovascular disease mortality: The MESA study. Circulation. 2022;146(3):229239. doi:10.1161/CIRCULATIONAHA.122.059174
  28. Heine M, Lategan F, Erasmus M, et al. Health education interventions to promote health literacy in adults with selected non-communicable diseases living in low-to-middle income countries: A systematic review and meta-analysis. J Eval Clin Pract. 2021;27(6):14171428. doi:10.1111/jep.13554
  29. Bowry AD, Lewey J, Dugani SB, Choudhry NK. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. Can J Cardiol. 2015;31(9):11511159. doi:10.1016/j.cjca.2015.06.028
DOI: https://doi.org/10.5334/aogh.4497 | Journal eISSN: 2214-9996
Language: English
Submitted on: Jun 6, 2024
Accepted on: Aug 5, 2024
Published on: Aug 21, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Natalie L. Nabaty, Tushar Menon, Garrett Trang, Aditya Vijay, Lama Chogyal, Renzo Cataldo, Navin Govind, Pankaj Jain, Priti Singh, Navaz Dolasa, Mandeep Sahani, Prakash Deedwania, Krishnaswami Vijayaraghavan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.